615.678.5544
     
Make A Payment

27 Feb

Posted at 09:58h in Blog

When Jennifer found her bladder leakage getting worse, she didn’t know what to do. She worked every day at Female Urology Associates of Nashville to help women with the same issues she was now facing, but she wasn’t sure where to begin. At 40 years old and with three kids, she couldn’t believe she was having bladder issues. Thinking this was only a problem for older women, she suffered in silence. Until finally, enough was enough. Urinary incontinence and bladder leakage had been holding Jennifer back from important moments in her life, and she was anxious and embarrassed by leakage...

27 Jul

Posted at 10:16h in News

Female Urology of Nashville is, the United States’ first, all-female urological surgical group, board-certified in Female Pelvic Medicine and Reconstructive Surgery. As the region’s recognized leaders in female urology, Drs. Marcy Abel, Tara Allen and Harriette Scarpero extend compassionate care in both medical and cosmetic urology. On Wednesday, September 5, the group will celebrate its one-year anniversary with an open house from 1 p.m. to 5 p.m. at their clinic in Nashville, Tennessee. “We are dedicated to providing each patient with quality, patient-centered care, personalized to them,” said Lesley Haun, practice administrator. “Every patient is unique, and we believe...

13 Nov

Posted at 12:06h in News

Do you know what OAB is? It is an abbreviation for the term "overactive bladder." This term describes a collection of symptoms: urianary frequency, urgency and sometimes leakage with the urge. Maybe you have these symptoms and have tried treatments such as medication. There are many medicines on the market for OAB: oxybutynin, tolterodine (Detrol LA), solifenacin (Vesicare), darifenacin (Enablex), and trospium chloride (Sanctura). Some of you may already have symptom control from these medications, but some of you are looking for another option. In the past 3 months there are several new options! There is a new class of medication,...

13 Nov

Posted at 11:59h in News

On August 24, 2011 the FDA approved onabotulinum toxin A (Botox) for injection into the bladder for treatment of urinary incontinence due to bladder overactivity associated with a neurologic condition such as spinal cord injury, multiple sclerosis, stroke and many other conditions. This approval makes a new option available in patients suffering with these conditions. It will be particularly useful in patients who cannot tolerate or received no benefit from the usual bladder relaxant medications called anticholinergics. I have been using Botox in the bladders of patients off-label (before FDA approval) for several years based on promising results in the...